Quest Diagnostics Inc (DGX) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year PR...

Form 8-K - Current report

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year...

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals PR...

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025 PR...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ...